| DB ID | MyCo_6045 |
| Title | Changes in plasma kynurenic acid concentration in septic shock patients undergoing continuous veno-venous haemofiltration |
| Year | 2013 |
| PMID | 24043287 |
| Fungal Diseases involved | Candida septic shock |
| Associated Medical Condition | Acute kidney injury |
| Genus | Candida |
| Species | glabrata |
| Organism | Candida glabrata |
| Ethical Statement | This prospective observational study was conducted in the First Clinic of Intensive Therapy at the Medical University of Lublin, Poland. The study was conducted in accordance with the intensive care unit (ICU) protocol, the Declaration of Helsinki and applicable regulatory requirements as approved by the Institutional Review Board and the local institutional ethics committee. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Plasma |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Kynurenic acid |
| Biomarker Full Name | Kynurenic acid |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Poland |
| Cohort | Adult patients treated with CVVH due to AKI related to septic shock were enrolled. Forty septic shock patients with AKI were studied. |
| Cohort No. | 40 |
| Age Group | 60±12 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Analytic |
| Analysis Method | Prismaflex CVVH monitor |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Prismaflex CVVH monitor |
| Up Regulation Down Regulation | Decrease |
| Sequence Data | None |
| External Link | None |
